Triple combination targeting PI3K, ER, and CDK4/6 inhibits growth of ER-positive breast cancer resistant to fulvestrant and CDK4/6 or PI3K inhibitor.
作者信息
Karimi Leena, Alves Carla L, Terp Mikkel G, Tuttolomondo Martina, Portman Neil, Ehmsen Sidse, Johansen Lene E, Bak Martin, Lim Elgene, Ditzel Henrik J
机构信息
Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark.
Garvan Institute of Medical Research, Darlinghurst, Sydney, New South Wales, Australia.
出版信息
Cancer Commun (Lond). 2023 Jun;43(6):720-725. doi: 10.1002/cac2.12425. Epub 2023 Apr 26.
Abstract
摘要
Zotero 插件